the Regulation of Total Value Repayment. It bases on consolidated financial statement yearly 2017 equals to 1,214,621,392 baht which is the last financial statement. The details are as follow; • Real

the same period of last year mainly due to lower aluminium prices. However, when comparing with previous quarter, it was decreased only 1.92% 2. Cost of sales was 403.56 million Baht or 102.57% of sales

Company Limited (“IVL” or the “Company”) would like to inform that it has, through its indirect subsidiary Indorama Ventures Holdings LP, signed a definitive Share Purchase Agreement on 3rd December 2019

, Indonesia and India markets experienced in 2019. For Malaysia market, although the TIV shown slightly improved from 2018, but it does not translate into a higher sales revenue mainly the increase was

to the same period of 2019,it showed a loss of Baht 18.90 million.

the 3-month period is 95.7 million baht decrease from the same period of the previous year 36.4% As a result of the reduction in the number of IT Junction branches that did not meet the target, the

to the hospital. In regard to the subsidiary, Asia Medical & Agricultural Laboratory and Research Center (“AMARC”), its service revenues grew by 12.60% as it provides laboratory testing and analyzing

Company’s connected person, for use as the Company’s office and business premises, which will expire on July 31, 2020. In this regard, the Board of Directors deemed it appropriate to authorize the Executive

Shareholders / Management / Business News / Opportunity day belongs to The Stock Exchange of Thailand . Website users agree and acknowledge that the copyright for it is The SET and can be used for education or

(Loss) Net Equity of shareholders of the Company for Q1/2024 and Q1/2023 was 72.24 million baht and 56.76 million baht, respectively. It increases 15.48 million baht or 27.27 % This is the fact that the